Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groups
Bee Teng Lim, Phyllis Butow, Ming Lo Sze, Afaf Girgis, Michael Jefford, David Goldstein, Daniel Costa
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | WILEY | Published : 2020
BACKGROUND/AIMS: This study compared rates of clinical trial participation and perceived adequacy of information provided prior to consent in migrant and Australian-born cancer patients, and explored factors associated with being approached and agreeing to participate. METHODS: We utilized data from a larger cross-sectional survey assessing disparities in patient-reported outcomes in Chinese, Arabic, or Greek migrant versus English-speaking Australian-born cancer patients. Participants completed a questionnaire eliciting demographic and disease details, communication challenges, whether invited and consented to a clinical trial, and if so, adequacy of information received. RESULTS: A total o..View full abstract
Awarded by Cancer Australia and Beyond Blue
This studywas funded by a grant from the Cancer Australia and Beyond Blue under thePrioritydriven Collaborative CancerResearch Scheme (Grant Number: 571009).